New chief has driven the business development of disruptive technologies in firms such as C.R. BARD, Ohmeda (BOC Healthcare), and Surgical Laser Technologies.
The SARS-CoV-2 IgG Antibody Test offers the first EUA for a semi-quantitative assay to help clinicians assess the level of an individual‘s immune response.
New high-quality care delivery model creates new category of solutions focused on delivering whole-person care for better health outcomes at lower cost.